Literature DB >> 25270770

Decision making in prenatal screening: money matters.

E Joanne Verweij1, Diederik Veersema, Eva Pajkrt, Monique C Haak.   

Abstract

The aim of this study is to determine the influence of withdrawal of reimbursement on the uptake of the first-trimester combined test. Until January 2007 the combined test was offered to all pregnant women in a designated geographical area as a pilot study before the introduction of the national screening program in the Netherlands, to test the logistic procedures. In January 2007 the insurance companies suddenly stopped paying for the combined test with respect to women aged ≤35 years by decision of the government. In 2006 the combined test was performed in 4616 women compared with 3459 who had the combined test in 2007, a reduction of 25% (95% CI 23.8-26.3%, p < 0.001). A decline was observed in the uptake of the combined test in women aged ≤35 years (p < 0.001) as opposed to an increase in uptake in women aged ≥36 years (p < 0.001). The financial impact on the uptake of the first-trimester combined test should not be underestimated.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Down syndrome; Prenatal screening; informed decision making; reimbursement; trisomy 21

Mesh:

Year:  2014        PMID: 25270770     DOI: 10.1111/aogs.12518

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Why NIPT should be publicly funded.

Authors:  Eline Maria Bunnik; Adriana Kater-Kuipers; Robert-Jan H Galjaard; Inez de Beaufort
Journal:  J Med Ethics       Date:  2020-04-10       Impact factor: 2.903

2.  Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study.

Authors:  Chuanlin Li; Leiyu Shi; Jiayan Huang; Xu Qian; Yingyao Chen
Journal:  BMC Health Serv Res       Date:  2016-01-14       Impact factor: 2.655

3.  Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access.

Authors:  Robert-Jan H Galjaard; Inez D de Beaufort; Eline M Bunnik; Adriana Kater-Kuipers
Journal:  J Med Ethics       Date:  2019-09-16       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.